HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric Hsi Selected Research

idelalisib

4/2017Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric Hsi Research Topics

Disease

5Neoplasms (Cancer)
11/2019 - 12/2009
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 04/2010
4Lymphoma (Lymphomas)
11/2021 - 06/2010
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019 - 11/2013
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2019 - 02/2012
2Multiple Myeloma
07/2006 - 11/2002
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
02/2004 - 11/2002
1Second Primary Neoplasms (Neoplasms, Second)
10/2023
1Cardiovascular Diseases (Cardiovascular Disease)
10/2023
1Hodgkin Disease (Hodgkin's Disease)
10/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2021
1Exanthema (Rash)
04/2017
1Fever (Fevers)
04/2017
1Hypotension (Low Blood Pressure)
04/2017
1Infections
04/2017
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
04/2017
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2017
1Fibrosis (Cirrhosis)
03/2011
1Pulmonary Arterial Hypertension
03/2011
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
03/2011
1T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic)
05/2005
1Splenomegaly
05/2005
1B-Cell Prolymphocytic Leukemia
05/2005
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
08/2004
1Large Granular Lymphocytic Leukemia
02/2004
1Cytopenia
02/2004

Drug/Important Bio-Agent (IBA)

3Rituximab (Mabthera)FDA Link
01/2019 - 11/2013
2Phosphotransferases (Kinase)IBA
11/2021 - 12/2009
2Lenalidomide (CC 5013)FDA Link
04/2017 - 03/2015
2Transcription Factors (Transcription Factor)IBA
02/2012 - 04/2010
2Vincristine (Oncovin)FDA LinkGeneric
07/2006 - 11/2002
2Dexamethasone (Maxidex)FDA LinkGeneric
07/2006 - 11/2002
2liposomal doxorubicin (Doxil)FDA Link
07/2006 - 11/2002
1Proteins (Proteins, Gene)FDA Link
11/2021
1Immunoconjugates (Immunoconjugate)IBA
11/2021
1MicroRNAs (MicroRNA)IBA
11/2019
1ofatumumabFDA Link
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
04/2017
1idelalisibIBA
04/2017
1Alanine Transaminase (SGPT)IBA
04/2017
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2017
1Cytotoxins (Cytolysins)IBA
04/2017
1Biomarkers (Surrogate Marker)IBA
12/2016
1MethyltransferasesIBA
03/2015
1DecitabineFDA Link
03/2015
1Azacitidine (5 Azacytidine)FDA Link
03/2015
1DNA (Deoxyribonucleic Acid)IBA
03/2015
1epratuzumabIBA
11/2013
1STAT5 Transcription FactorIBA
10/2012
1Reticulin (Reticular Fiber)IBA
03/2011
1Hypoxia-Inducible Factor 1IBA
03/2011
110-propargyl-10-deazaaminopterinFDA Link
03/2011
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
12/2010
1Daunorubicin (Cerubidine)FDA LinkGeneric
12/2010
1Imatinib Mesylate (Gleevec)FDA Link
12/2010
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2010
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2009
1Tyrosine (L-Tyrosine)FDA Link
12/2009
1Thalidomide (Thalomid)FDA Link
07/2006
1fludarabineIBA
05/2005
1Pyridinolcarbamate (P23)IBA
08/2004
1Anaplastic Lymphoma KinaseIBA
08/2004
1NucleophosminIBA
08/2004
1CytokinesIBA
02/2004
1Non-Receptor Type 6 Protein Tyrosine PhosphataseIBA
11/2002

Therapy/Procedure

8Therapeutics
10/2023 - 11/2002
5Drug Therapy (Chemotherapy)
10/2023 - 11/2002
1Radiotherapy
10/2023
1Immunotherapy
01/2019
1Splenectomy
05/2005